Monoclonal antibody treatment will be available to patients aged over 50 years hospitalised with COVID-19
Ronapreve, a cocktail of casirivimab and imdevimab, works by binding to COVID-19's spike protein, stopping it from infecting the body’s cells.…
Published: 20 September 2021